Skip to main content
TTrialFinderData
TrialFinderData is for informational purposes only and does not provide medical advice. Always talk to your doctor.

Arthritis, Rheumatoid Clinical Trials

Reviewed by TrialFinderData Editorial Team · Updated

10 recruiting trials for Arthritis, Rheumatoid. Eligibility criteria explained in plain English.

TrialFinderData lists 10 Arthritis, Rheumatoid clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.

Every phased trial in this set is Phase 4 (1 of the listed studies); the remaining records are observational or have no phase recorded on ClinicalTrials.gov.

Research is led by Aalborg University Hospital (1), London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's (1), Qilu Hospital of Shandong University (1), among the most active sponsors registered for these trials.

The most frequently studied intervention is Laser Based Photoacoustic Tomography, MRI, Ultrasound (procedure, 2 trials), followed by Fecal Microbial transplant, Placebo capsules.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
10
Total Trials
10
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Track Arthritis, Rheumatoid trials

Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.

Recruiting Trials

Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.

RECRUITINGNCT04731831

Characterization of Immunogenicity of TNF Inhibitors in Arthritis Patients With Poorer Treatment Response.

The aim of the study is to explore whether the influence of gender, tobacco smoking and obesity on treatment response in tumor necrosis factor inhibitors (TNFIs) can be explained...

Sponsor: Aalborg University HospitalEnrolling: 1201 location
RECRUITINGNCT05790356

Fecal Microbial Transplantation for Rheumatoid Arthritis Trial

This clinical trial will investigate the effects of capsules containing stool from healthy donors, called fecal microbial transplant (FMT), in rheumatoid arthritis patients.

Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sEnrolling: 301 location
RECRUITINGPhase 4NCT05626348

The Clinical Efficacy of Immunomodulators in RA Patients

This study includes naive patients and csDMARDs-IR RA patients, treated with different regimens such as Iguratimod combination of different csDMARDs, or csDMARD with TNF...

Sponsor: Qilu Hospital of Shandong UniversityEnrolling: 4001 location
RECRUITINGNCT07017686

The Reboot Study: A Safety Study of Abdominal Vagus Nerve Stimulation for Moderate to Severe Drug Refractory Rheumatoid...

This open label clinical trial aims to assess the safety of abdominal vagus nerve stimulation (aVNS) for moderate to severe, adult-onset rheumatoid arthritis (RA) that has not...

Sponsor: The Bionics Institute of AustraliaEnrolling: 53 locations
RECRUITINGNCT07045896

Fucoidan in the Treatment of Active Rheumatoid Arthritis

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint destruction and autoantibody production. Scavenger receptor-A (SR-A), a pattern recognition...

Sponsor: Peking University People's HospitalEnrolling: 401 location
RECRUITINGNCT00748254

Laser-based Photoacoustic Tomography of Human Inflammatory Arthritis

The purpose of this feasibility study is to determine if a new emerging technology called photoacoustic tomography (PAT) can be adapted for use in humans for the detection of...

Sponsor: University of MichiganEnrolling: 1131 location
RECRUITINGNCT06718569

Pain in Inflammatory Joint Diseases

Our primary objective is to better understand the etiology and consequences of chronic paint by using an explorative approach to identify phenotypes and endotypes of patients with...

Sponsor: Diakonhjemmet HospitalEnrolling: 3501 location
RECRUITINGNCT04191395

Evolution and Treatments of Chronic Inflammatory Systemic Diseases

Patients with chronic inflammatory diseases (CID) followed in gastroenterology, dermatology and rheumatology have physiopathological, epidemiological and therapeutic focal points....

Sponsor: Centre Hospitalier Universitaire de BesanconEnrolling: 30001 location
RECRUITINGNCT06246123

A Study of Jyseleca Tablet (Filgotinib Maleate) in Korean Participants

The purpose of this study is to collect and evaluate the following information in relation to the safety and the efficacy of Jyseleca tablet (Filgotinib Maleate) 100 milligram...

Sponsor: Eisai Korea Inc.Enrolling: 204020 locations
RECRUITINGNCT05657847

Novel Complex Radiodiagnostics of Peripherial Arthropathies

Chronic peripherial arthritides are common diseases with soaring public health consequences. Our goal is to assess the role of photon-counting detector computed tomography in the...

Sponsor: Semmelweis UniversityEnrolling: 5003 locations

Frequently Asked Questions

There are currently 10 clinical trials for Arthritis, Rheumatoid, with 10 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.

To join a clinical trial for Arthritis, Rheumatoid, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.

Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Arthritis, Rheumatoid, representing treatments closest to potential FDA approval.

Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.

Sources: ClinicalTrials.gov, FDA
Last updated:

Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.